Fertility startup ‘rejuvenates’ human eggs to boost chances of conception

German biotech startup Ovo Labs has developed new technologies to “rejuvenate” human eggs, potentially boosting the chances of conception.  The therapeutics are designed to enhance in vitro fertilisation (IVF), one of the most transformative advances in reproductive medicine. The first baby was born via IVF more than 40 years ago. Since then, the technology has helped millions of women get pregnant. However, IVF can put significant emotional, psychological, and financial strain